about
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2Biomarkers in multiple sclerosis: an update for 2014Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selectionA type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisThe orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon responseT cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsPeptidic complex mixtures as therapeutic agents in CNS autoimmunity.Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphismsSustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort.Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitisThe OSCAR-IB consensus criteria for retinal OCT quality assessmentNeuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.Daclizumab (anti-CD25) in multiple sclerosis.Autoimmunity in Lyme disease: molecular cloning of antigens recognized by antibodies in the cerebrospinal fluid.Functional HLA-DM on the surface of B cells and immature dendritic cells.Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.Future immunotherapies in multiple sclerosis.New approaches to investigating heterogeneity in complex traitsImmunological questions on hematopoietic stem cell transplantation for multiple sclerosis.Nogo receptor is involved in the adhesion of dendritic cells to myelin.A truncation variant of the cation channel P2RX5 is upregulated during T cell activation.Tuberous sclerosis complex and Wolff-Parkinson-White syndromeHeterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis.Quantitative T2' imaging in patients with clinically isolated syndromeHaematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationCentral role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesionsAutoantigens act as tissue-specific chemoattractants.Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.Antigen-specific therapies in multiple sclerosis.Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.The value of animal models for drug development in multiple sclerosis.Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathyGenomics in multiple sclerosis--current state and future directions.[Multiple sclerosis. New therapeutic strategies in the experimental stage][Multiple sclerosis]Multiple sclerosis: a complicated picture of autoimmunity.Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.Getting specific: monoclonal antibodies in multiple sclerosis.Antigen-specific therapies in MS - Current concepts and novel approaches.
P50
Q24657388-33AFDFD7-F298-497A-9B23-21948753C9C4Q26826819-49339F5E-5A22-4EAC-9853-DE340BB73279Q27666863-27741822-435C-4428-8CD2-3FFB04D9B650Q28257957-142BDFC2-685D-439B-A0F0-1E8386749223Q28541466-8E929366-79E4-4AEA-8975-6B33E05DD706Q28704590-55B99415-4738-409E-9473-34195C4DF7E1Q33199995-3A51AC1B-6417-4F0E-AC01-4FC7405881D1Q33378475-BCF3808D-78FB-4EDE-ACE3-D00BD4F2CDAAQ34154060-06CB5AF7-99C1-4892-BAD1-46CE85B63C8BQ34234228-B0480ECE-5C49-42F7-AE02-8BF8DF9DE770Q34247079-11C2F4E7-DCEA-45FE-806D-009080E1D76FQ34255511-D665B2C9-54D4-4933-960A-8B87715DDC11Q34596171-E3641D06-CE1A-43BE-827B-A0A775F47BC9Q34661536-8C07973D-8053-4086-A6C1-B834DC53513CQ34662362-74DFDFC7-FD7A-4300-8A93-F5E2F4A0FCAEQ34667803-38F5B700-442B-49A8-894A-D1C8DE518BC2Q34674896-2BC6D216-B58B-4C11-BD3B-403A7B4E78CDQ35190238-CACCCD4A-DB3F-4A33-8AE0-293D4F715FBDQ35200318-AE9A2DB0-ECB2-4E94-BB99-96B35043807FQ35204107-DEC48B82-F826-4460-9B76-23C11DB9C0DBQ35225938-ADB17EBB-8F81-4F37-8A68-17DC00271BA5Q35236818-A4D12585-5A7B-4DA9-B9F1-3CB02B783A97Q35258306-FA2609A5-8C2D-4611-BE41-2B321133D5DDQ35491552-8EE68550-D2C8-4FC0-A92E-EF8E418F113DQ35980966-90224AAC-D53D-4438-8FA8-1DBFDA4BB304Q36020897-B21DDDDF-9361-462B-98AC-09D41BBA2F87Q36072420-CF6CAB8E-E6A3-4370-A3E3-036A9BCAB1E8Q36139951-51AE7CA4-B269-4A37-AEB7-D63EC79BA7BCQ36218461-B64D12AB-EC58-478D-9879-37B36EAE1985Q36327373-647B1E6D-34B0-4233-BE67-0B8D4DE107DAQ36402704-04BBFAA1-8E01-41B3-AF6C-52F56307C37FQ36458937-1C35171A-266E-4EEB-A6F9-D942CE0BB0E5Q36764988-36D37775-3DF3-44B5-90A7-4D6BF2A4C7E8Q36776753-47993071-DAA2-4E83-BBB9-ED860D540580Q36863921-B0E12F09-868F-4706-A951-4F57B53138C6Q36881566-DC23EF38-A643-4F3F-B15E-54E0DB8641FAQ36915907-B37F3551-A145-4951-863A-6293D59483DBQ37030433-798D6408-D88F-41B3-B957-DEDAEFCDE045Q37165875-3F6CF76E-D068-4ECC-A9A8-256E105CD9E8Q37206577-C2518A78-1CFC-4755-B1C9-2B19417911C7
P50
description
researcher
@en
wetenschapper
@nl
name
R Martin
@ast
R Martin
@en
R Martin
@nl
type
label
R Martin
@ast
R Martin
@en
R Martin
@nl
prefLabel
R Martin
@ast
R Martin
@en
R Martin
@nl
P106
P31
P496
0000-0002-0982-1329